Literature DB >> 8627722

Mechanism of interferon action: functionally distinct RNA-binding and catalytic domains in the interferon-inducible, double-stranded RNA-specific adenosine deaminase.

Y Liu1, C E Samuel.   

Abstract

The 1,226-amino-acid sequence of the interferon-inducible double-stranded RNA-specific adenosine deaminase (dsRAD) contains three copies (RI, RII, and RIII) of the highly conserved subdomain R motif commonly found in double-stranded RNA-binding proteins. We have examined the effects of equivalent site-directed mutations in each of the three R-motif copies of dsRAD on RNA-binding activity and adenosine deaminase enzyme activity. Mutations of the R motifs were analyzed alone as single mutants and in combination with each other. The results suggest that the RIII copy is the most important of the three R motifs for dsRAD activity and that the RII copy is the least important. The RIII mutant lacked detectable enzymatic activity and displayed greatly diminished RNA-binding activity. Site-directed mutations within the highly conserved CHAE sequence of the postulated C-terminal deaminase catalytic domain destroyed enzymatic activity but did not affect RNA-binding activity. These results indicate that the three copies of the RNA-binding R subdomain are likely functionally distinct from each other and also from the catalytic domain of dsRAD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627722      PMCID: PMC190025     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Mechanism of interferon action: identification of a RNA binding domain within the N-terminal region of the human RNA-dependent P1/eIF-2 alpha protein kinase.

Authors:  S J McCormack; D C Thomis; C E Samuel
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

2.  Two RNA-binding motifs in the double-stranded RNA-activated protein kinase, DAI.

Authors:  S R Green; M B Mathews
Journal:  Genes Dev       Date:  1992-12       Impact factor: 11.361

3.  A conserved double-stranded RNA-binding domain.

Authors:  D St Johnston; N H Brown; J G Gall; M Jantsch
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

Review 4.  Mutations and A/I hypermutations in measles virus persistent infections.

Authors:  R Cattaneo; M A Billeter
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

5.  Two functionally distinct RNA-binding motifs in the regulatory domain of the protein kinase DAI.

Authors:  S R Green; L Manche; M B Mathews
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

Review 6.  The eIF-2 alpha protein kinases, regulators of translation in eukaryotes from yeasts to humans.

Authors:  C E Samuel
Journal:  J Biol Chem       Date:  1993-04-15       Impact factor: 5.157

7.  Control of kinetic properties of AMPA receptor channels by nuclear RNA editing.

Authors:  H Lomeli; J Mosbacher; T Melcher; T Höger; J R Geiger; T Kuner; H Monyer; M Higuchi; A Bach; P H Seeburg
Journal:  Science       Date:  1994-12-09       Impact factor: 47.728

Review 8.  Tumor-suppressor genes: news about the interferon connection.

Authors:  P Lengyel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

9.  Relatedness of an RNA-binding motif in human immunodeficiency virus type 1 TAR RNA-binding protein TRBP to human P1/dsI kinase and Drosophila staufen.

Authors:  A Gatignol; C Buckler; K T Jeang
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

10.  Preferential selection of adenosines for modification by double-stranded RNA adenosine deaminase.

Authors:  A G Polson; B L Bass
Journal:  EMBO J       Date:  1994-12-01       Impact factor: 11.598

View more
  38 in total

1.  Chimeric double-stranded RNA-specific adenosine deaminase ADAR1 proteins reveal functional selectivity of double-stranded RNA-binding domains from ADAR1 and protein kinase PKR.

Authors:  Y Liu; M Lei; C E Samuel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  The human but not the Xenopus RNA-editing enzyme ADAR1 has an atypical nuclear localization signal and displays the characteristics of a shuttling protein.

Authors:  C R Eckmann; A Neunteufl; L Pfaffstetter; M F Jantsch
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

3.  Nucleocytoplasmic distribution of human RNA-editing enzyme ADAR1 is modulated by double-stranded RNA-binding domains, a leucine-rich export signal, and a putative dimerization domain.

Authors:  Alexander Strehblow; Martina Hallegger; Michael F Jantsch
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

4.  Host response to polyomavirus infection is modulated by RNA adenosine deaminase ADAR1 but not by ADAR2.

Authors:  Cyril X George; Charles E Samuel
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

5.  Adenosine deaminase acting on RNA 1 (ADAR1) suppresses the induction of interferon by measles virus.

Authors:  Zhiqun Li; Kristina M Okonski; Charles E Samuel
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 6.  Adenosine deaminases acting on RNA, RNA editing, and interferon action.

Authors:  Cyril X George; Zhenji Gan; Yong Liu; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2010-12-23       Impact factor: 2.607

7.  Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing.

Authors:  Guangyan Liu; Xiancai Ma; Zhe Wang; Kousho Wakae; Yaochang Yuan; Zhangping He; Hironori Yoshiyama; Hisashi Iizasa; Hui Zhang; Mami Matsuda; Ryuichi Sugiyama; Zhiyu Yuan; Masamichi Muramatsu; Linghua Li
Journal:  J Biol Chem       Date:  2019-07-30       Impact factor: 5.157

8.  Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown.

Authors:  Hachung Chung; Jorg J A Calis; Xianfang Wu; Tony Sun; Yingpu Yu; Stephanie L Sarbanes; Viet Loan Dao Thi; Abigail R Shilvock; H-Heinrich Hoffmann; Brad R Rosenberg; Charles M Rice
Journal:  Cell       Date:  2018-01-25       Impact factor: 41.582

9.  Effects of conserved RNA secondary structures on hepatitis delta virus genotype I RNA editing, replication, and virus production.

Authors:  Geetha C Jayan; John L Casey
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

10.  Evidence for auto-inhibition by the N terminus of hADAR2 and activation by dsRNA binding.

Authors:  Mark R Macbeth; Arunth T Lingam; Brenda L Bass
Journal:  RNA       Date:  2004-10       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.